Amylyx Pharmaceuticals, Inc. (AMLX): Weighted Average Diluted Shares
94.57M
Year ended 2025-12-31
+17.4%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 94.57M | +38.8% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | 68.14M | -2.6% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | 69.99M | +19.7% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | 58.50M | +788.1% | 2024-02-22, From 2022-01-01 |
| 2021-12-31 | 6.59M | n/a | 2024-02-22, From 2021-01-01 |